-
Mashup Score: 0Real-World Experience on the Safety Efficacy of Antegrade Administration of JELMYTO® for UTUC via Percutaneous Nephrostomy Tube - Kyle Rose - 2 year(s) ago
Kyle Rose, SUO Clinical Fellow at Moffitt Cancer Center joins Alicia Morgans in highlighting his AUA presentation on the real-world data on the antegrade administration of reverse thermal mitomycin (JEMLYTO®) for primary chemoablation of upper tract urothelial carcinoma (UTUC). Based on results from the pivotal OLYMPUS trial, JELMYTO® is currently approved for low-grade UTUC. Dr. Rose and…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0
Neal Shore joins Alicia Morgans to discuss pioneering work on establishing the importance of multidisciplinary teams in the management of urologic oncology patients. This was a plenary presentation at the AUA led by Leonard Gomella and Neal Shore and Michael Cookson as panelists. They discussed the importance of a collaborative approach to optimizing patient care. Drs. Morgans and Shore also…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet-
The importance of multidisciplinary collaboration in #Urology clinics. Neal Shore @AtlanticUrology joins @CaPsurvivorship @DanaFarber to discuss work presented in a plenary presentation at #AUA22 > https://t.co/oOZTyzH6IA @michaelcookso18 @LeonardGomella https://t.co/nsR5VARfUm
-
-
Mashup Score: 0Real-World Experience on the Safety Efficacy of Antegrade Administration of JELMYTO® for UTUC via Percutaneous Nephrostomy Tube - Kyle Rose - 2 year(s) ago
Kyle Rose, SUO Clinical Fellow at Moffitt Cancer Center joins Alicia Morgans in highlighting his AUA presentation on the real-world data on the antegrade administration of reverse thermal mitomycin (JEMLYTO®) for primary chemoablation of upper tract urothelial carcinoma (UTUC). Based on results from the pivotal OLYMPUS trial, JELMYTO® is currently approved for low-grade UTUC. Dr. Rose and…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet-
Real-world experience on the safety and efficacy of antegrade administration of @jelmyto® for #UTUC via percutaneous nephrostomy tube. @KyleRoseMD @MoffittNews joins @CaPsurvivorship @DanaFarber to discuss his #AUA22 presentation. #WatchNow > https://t.co/0dCTaUbkUb @UroGenPharma https://t.co/lKx38wsbvq
-
-
Mashup Score: 3Best Poster Award Winners - 2 year(s) ago
MP01-09: Risk Factors for A Delayed Improvement in Lower Urinary Tract Symptoms Following Convective Water Vapor Thermal TherapyMay 13, 2022 7:00 AM to 8:15 AMSarang Janakiraman · Loyola MedicineMP02-15: Impact of MV140 on patient related burden of disease associated with the management of recurrent urinary tract infections (rUTI)May 13, 2022 7:00 AM to 8:15 AMCurtis NickelMP03-16: Feasibility,…
Source: app.swapcard.comCategories: Latest Headlines, UrologyTweet-
Have you checked out the BEST posters from #AUA22 yet⁉️✨ Access the latest science in the field of #urology at your finger-tips! ➡️ https://t.co/fy4DTxBhqG https://t.co/8fVQJJtBFk
-
-
Mashup Score: 0
Neal Shore joins Alicia Morgans to discuss pioneering work on establishing the importance of multidisciplinary teams in the management of urologic oncology patients. This was a plenary presentation at the AUA led by Leonard Gomella and Neal Shore and Michael Cookson as panelists. They discussed the importance of a collaborative approach to optimizing patient care. Drs. Morgans and Shore also…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet-
The importance of multidisciplinary collaboration in #Urology clinics. Neal Shore @AtlanticUrology joins @CaPsurvivorship @DanaFarber to discuss work presented in a plenary presentation at #AUA22 > https://t.co/oOZTyzpvR2 @michaelcookso18 @LeonardGomella https://t.co/5vYZnsnP9t
-
-
Mashup Score: 5Best Poster Award Winners - 2 year(s) ago
MP01-09: Risk Factors for A Delayed Improvement in Lower Urinary Tract Symptoms Following Convective Water Vapor Thermal TherapyMay 13, 2022 7:00 AM to 8:15 AMSarang Janakiraman · Loyola MedicineMP02-15: Impact of MV140 on patient related burden of disease associated with the management of recurrent urinary tract infections (rUTI)May 13, 2022 7:00 AM to 8:15 AMCurtis NickelMP03-16: Feasibility,…
Source: app.swapcard.comCategories: Latest Headlines, UrologyTweet-
The Best Posters of #AUA22 are ✨NOW AVAILABLE✨ to view on-demand‼️ Access the latest science in the field of #urology!➡️ https://t.co/fy4DTxBhqG https://t.co/Ij6bXOvP8G
-
-
Mashup Score: 1
Matthew Cooperberg joins Charles Ryan in a discussion on risk-stratified therapy for localized prostate cancer discussing who the patient is that should get active surveillance (AS) vs who shouldn’t. To begin their conversation, Dr. Cooperberg previews the latest data coming from the AUA Quality Registry (AQUA) on the percentage of patients receiving active surveillance. This full data will be…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet-
Risk stratification for localized #ProstateCancer. @dr_coops @UCSFCancer joins @charlesryanmd @PCFnews discussing which patients should recieve #ActiveSurveillance and who should not. #WatchNow on UroToday > https://t.co/BENj64GYfm @ASCO #GU22 @AmerUrological #AUA22 https://t.co/5Td7CPMCP6
-
-
Mashup Score: 0Best Poster Award Winners - 2 year(s) ago
MP01-09: Risk Factors for A Delayed Improvement in Lower Urinary Tract Symptoms Following Convective Water Vapor Thermal TherapyMay 13, 2022 7:00 AM to 8:15 AMSarang Janakiraman · Loyola MedicineMP02-15: Impact of MV140 on patient related burden of disease associated with the management of recurrent urinary tract infections (rUTI)May 13, 2022 7:00 AM to 8:15 AMCurtis NickelMP03-16: Feasibility,…
Source: app.swapcard.comCategories: Latest Headlines, UrologyTweet-
The Best Posters of #AUA22 are ✨NOW AVAILABLE✨ to view on-demand‼️ Access the latest science in the field of #urology!➡️ https://t.co/fy4DTxBhqG https://t.co/GBMU3ezTvm
-
-
Mashup Score: 1Real-World Experience on the Safety Efficacy of Antegrade Administration of JELMYTO® for UTUC via Percutaneous Nephrostomy Tube - Kyle Rose - 2 year(s) ago
Kyle Rose, SUO Clinical Fellow at Moffitt Cancer Center joins Alicia Morgans in highlighting his AUA presentation on the real-world data on the antegrade administration of reverse thermal mitomycin (JEMLYTO®) for primary chemoablation of upper tract urothelial carcinoma (UTUC). Based on results from the pivotal OLYMPUS trial, JELMYTO® is currently approved for low-grade UTUC. Dr. Rose and…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet-
Real-world experience on the safety and efficacy of antegrade administration of @jelmyto® for #UTUC via percutaneous nephrostomy tube. @KyleRoseMD @MoffittNews joins @CaPsurvivorship @DanaFarber to discuss his #AUA22 presentation. #WatchNow > https://t.co/0dCTaUbkUb @UroGenPharma https://t.co/OrKSOktBiF
-
-
Mashup Score: 1
Neal Shore joins Alicia Morgans to discuss pioneering work on establishing the importance of multidisciplinary teams in the management of urologic oncology patients. This was a plenary presentation at the AUA led by Leonard Gomella and Neal Shore and Michael Cookson as panelists. They discussed the importance of a collaborative approach to optimizing patient care. Drs. Morgans and Shore also…
Source: UroTodayCategories: Latest Headlines, UrologyTweet-
The importance of multidisciplinary collaboration in #Urology clinics. Neal Shore @AtlanticUrology joins @CaPsurvivorship @DanaFarber to discuss work presented in a plenary presentation at #AUA22 > https://t.co/oOZTyzpvR2 @michaelcookso18 @LeonardGomella https://t.co/06yAkdSseq
-
Real-world experience on the safety and efficacy of antegrade administration of @jelmyto® for #UTUC via percutaneous nephrostomy tube. @KyleRoseMD @MoffittNews joins @CaPsurvivorship @DanaFarber to discuss his #AUA22 presentation. #WatchNow > https://t.co/0dCTaUbkUb @UroGenPharma https://t.co/ndpwbwSBk7